3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
50
Breast Neoplasms
25
Neoplasms
6
Neoplasm Metastasis
3
Prostate Adenocarcinoma
2
Breast Neoplasms, Male
2
Advanced Breast Cancer
2
Recurrence
1
Primary Ovarian Insufficiency
1
PSA Level Greater Than Two
1
Osteitis Deformans
1
Lymphatic Metastasis
1
Infertility
1
Hormone-sensitive Metastatic Breast Cancer
1
Hormone Sensitive Prostate Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
Advanced Metastatic Breast Cancer
1
Interventions
vistusertib
1
ribociclib
1
Tamoxifen
1
Letrozole
1
Goserelin
1
Fulvestrant
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Advanced Metastatic Breast Cancer
×
Goserelin
×
Clear all
NCT02278120
2024-03-12
MONALEESA-7
Novartis
Phase 3
Completed
672 enrolled
16 charts
1 FDA